2-Methyl-2-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)propanenitrile, 95.0%, 1g

(7S)-7-Chloro-7-deoxylincomycin hydrochloride monohydrate, 98.0%, 5g

1-CYANOACETYL-3,5-DIMETHYLPYRAZOLE, 97.0%, 10g

Lambda Hind III / phiX Hae III Marker

N-(2-Aminophenyl)cyclopropanesulfonamide, 98%, 250mg

3-(aminomethyl)-1-methylquinolin-2(1H)-one hydrochloride, 95.0%, 500mg

N-TERT-BUTYL-4-HYDROXYBENZAMIDE, 95.0%, 1g

1,7-Diazaspiro[4.4]nonan-6-one hydrochloride, 97%, 250mg

(2-(Benzyloxy)-3-fluorophenyl)boronic acid, 95.0%, 5g

(2-Methoxy-phenylamino)-acetic acid hydrazide, 1g

(R)-Tert-butyl (1-(3-(benzyloxy)-2-hydroxypropyl)-2-(1-(benzyloxy)-2-methylpropan-2-yl)-6-fluoro-1H-indol-5-yl)carbamate, 97%, 1g

2-Bromo-4,5-dichloropyridine, 95.0%, 250mg

4-(2,2,2-TRIFLUORO-1,1-DIHYDROXYETHYL)BENZONITRILE, 95%, 100mg